Midline (qualifier value)
Actuate Therapeutics’ Pancreatic Cancer Drug Elraglusib Shows Survival Benefit in Phase 2 Study
Actuate Therapeutics; Elraglusib; Pancreatic cancer; Phase 2 trial; Median overall survival; Gemcitabine; Nab-paclitaxel; Metastatic pancreatic ductal adenocarcinoma; Survival benefit; ASCO 2025
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Midline (qualifier value), Wages, Pharma, Worker
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
2023, Midline (qualifier value), Gilead, Wages, Average, Highest
Compensation Trends in the Pharmaceutical and Biotech Industry: 2023 Insights
pharmaceutical industry, biotech companies, median salary, employee pay, compensation trends, 2023